# ClinicalTrials.gov record history: NCT00608023

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct00608023-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct00608023.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `19467b19e3ae4a9498121cc39329448566ba245603c359fbc1fd6f0e78feec4d`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2008-01-23 | 2008-01-23 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=1&tab=history) | `12e98db2ec3c733309e7a0ed1757dc6502526f82f1cc8af1a4f4281fdd01bbc0` |
| 2 | 2011-11-22 | 2011-11-22 | COMPLETED | INTERVENTIONAL | Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=2&tab=history) | `05edc770a8b22d48ba0cc0786d9113f1a43a75ac19333752e69a4f4e45cb4385` |
| 3 | 2013-11-25 | 2013-11-25 | COMPLETED | INTERVENTIONAL | Arms and Interventions, Outcome Measures, Sponsor/Collaborators, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=3&tab=history) | `b13b06f1ea0798629a4b43c7bd16fcdec4c9dc7dc93b3b7bf1af3f854f39643e` |
| 4 | 2013-11-27 | 2013-11-27 | COMPLETED | INTERVENTIONAL | Adverse Events, Baseline Characteristics, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=4&tab=history) | `bd416e533aab2bdc7ceb5cf757748cf2b7acbdf8498453ef37c05c0fce8e0d4a` |
| 5 | 2014-03-27 | 2014-03-27 | COMPLETED | INTERVENTIONAL | Adverse Events, Arms and Interventions, Baseline Characteristics, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=5&tab=history) | `f57cc52ec770a4eedbb4fe454c6b1ee3dc86dd6f2f6ec9823d62905e6ceb8628` |
| 6 | 2022-03-29 | 2022-03-29 | COMPLETED | INTERVENTIONAL | Outcome Measures (Results), Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=6&tab=history) | `0b35352604ec39a39acbd83e0cbbbb3ba73d04d766558cfc6aadb8cfe4ea6b3b` |
| 7 | 2022-03-30 | 2022-03-30 | COMPLETED | INTERVENTIONAL | Adverse Events, More Information, Study Description, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=7&tab=history) | `6b7efe6ea71363fd906bc70a8e03f917d36c7836df25d11c36243b3e08a33ce3` |
| 8 | 2022-09-16 | 2022-09-16 | COMPLETED | INTERVENTIONAL | Contacts/Locations, IPDSharing, Limitations and Caveats, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=8&tab=history) | `12384bdc9ee3335b002f715019b68457abb1254d2fa8dde0e210961df86b1177` |